Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Huolin Zhong"'
Autor:
Heping Zhao, Anping Feng, Dan Luo, Tanwei Yuan, Yi-Fan Lin, Xuemei Ling, Huolin Zhong, Junbin Li, Linghua Li, Huachun Zou
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Among people living with HIV (PLHIV) on antiretroviral therapy (ART), the mortality of immunological non-responders (INRs) is higher than that of immunological responders (IRs). However, factors associated with immunological non-r
Externí odkaz:
https://doaj.org/article/5b033e7e44d14b578e787b8e976c496d
Autor:
Yaozu He, Weiyin Lin, Hong Li, Fei Gu, Huolin Zhong, Yun Lan, Yonghong Li, Pengle Guo, Fengyu Hu, Weiping Cai, Xiaoping Tang, Linghua Li, Sihan Zhou, Xiuyuan Hao
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 22, Pp 2686-2693 (2023)
Abstract. Background:. Hepatitis B surface antigen (HBsAg) clearance is vital for a functional cure of hepatitis B virus (HBV) infection. However, the incidence and predictors of HBsAg seroclearance in patients co-infected with HBV and human immunode
Externí odkaz:
https://doaj.org/article/a7447d312471484c9d96a9d5bfe447e7
Autor:
Weiyin Lin, Huolin Zhong, Chunyan Wen, Yaozu He, Xiaowen Zheng, Hong Li, Xiejie Chen, Haolan He, Jinfeng Chen, Lijuan Chen, Cong Liu, Xiaoping Tang, Weiping Cai, Linghua Li, Yanjie Yin
Publikováno v:
Chinese Medical Journal, Vol 135, Iss 22, Pp 2699-2705 (2022)
Abstract. Background:. Chronic liver disease has emerged as a leading cause of non-acquired immune deficiency syndrome (AIDS)-related mortality in hepatitis C virus (HCV)/human immunodeficiency virus (HIV)-coinfected patients. The relationship betwee
Externí odkaz:
https://doaj.org/article/e26007e294b4486da83e74827bb004fa
Autor:
Weiyin Lin, Liya Li, Pengle Guo, Yaozu He, Haolan He, Hong Li, Huolin Zhong, Cong Liu, Peishan Du, Weiping Cai, Xiaoping Tang, Linghua Li
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Background and aimsIt is necessary to identify simple biomarkers that can efficiently predict the efficacy of long-term antiretroviral therapy (ART) against human immunodeficiency virus (HIV), especially in underdeveloped countries. We characterized
Externí odkaz:
https://doaj.org/article/4d0734ffed42496abb0ac42624a634f4
Autor:
Xiaoman Chen, Yi Cao, Meijun Chen, Haodi Wang, Peishan Du, Hong Li, Huolin Zhong, Quanmin Li, Santao Zhao, Zhenjiang Yao, Wanshan Chen, Weiping Cai, Xiaoping Tang, Linghua Li
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
PurposeWe aimed to investigate the prevalence and risk factors of filamentous fungi (FF) carriage in human immunodeficiency virus (HIV)-infected patients in Guangdong province, along with its subsequent incidence of invasive fungal disease (IFD).Meth
Externí odkaz:
https://doaj.org/article/01abca95bcd0429dac28a5b90b9f8311
Autor:
Xiaojie Huang, Kathrine Meyers, Xinchao Liu, Xia Li, Tong Zhang, Wei Xia, Jiahua Hou, Aixin Song, Haolan He, Chongxi Li, Shenghua He, Weiping Cai, Huolin Zhong, Chengyu Huang, Shuiqing Liu, Hui Wang, Xuemei Ling, Ping Ma, Rongxia Ye, Gang Xiao, Taisheng Li, Ding Ding, Kristine Yaffe, Hui Chen, Yaokai Chen, Hao Wu
Publikováno v:
Frontiers in Psychiatry, Vol 9 (2018)
Background: Anxiety and depression continue to be significant comorbidities for people with HIV infection. We investigated the prevalence of and factors associated with anxiety and depression among adult HIV-infected patients across China.Methods: In
Externí odkaz:
https://doaj.org/article/a25f25c290bf4fec8e12c5750337b14c
Autor:
Jingliang Chen, Yaozu He, Huolin Zhong, Fengyu Hu, Yonghong Li, Yeyang Zhang, Xia Zhang, Weiyin Lin, Quanmin Li, Feilong Xu, Shaozhen Chen, Hui Zhang, Weiping Cai, Linghua Li
Publikováno v:
Virologica Sinica.
Autor:
Haolan He, Linghua Li, Pengle Guo, Yun Lan, Hong Li, Jian Wang, Xiaoting Chen, Cong Liu, Jin-Feng Chen, Xiaoping Tang, Weiping Cai, Xiejie Chen, Pei-Shan Du, Huolin Zhong, Fengyu Hu, Liya Li
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology, Vol 11 (2021)
Dual therapy with lopinavir/ritonavir (LPV/r) plus lamivudine (3TC) has been demonstrated to be non-inferior to the triple drug regimen including LPV/r plus two nucleoside reverse transcriptase inhibitors (NRTIs) in 48-week studies. However, little i
Autor:
Weiyin Lin, Chunyan Wen, Xiejie Chen, Haolan He, Yonghong Li, Hong Li, Lijuan Chen, Peishan Du, Caiqiong Li, Huolin Zhong, Weiping Cai, Linghua Li
Publikováno v:
SSRN Electronic Journal.
Autor:
Yun Lan, Haolan He, Linghua Li, Jingmin Nie, Xiejie Chen, Huolin Zhong, Fengyu Hu, Xiaoping Tang, Jin-Feng Chen, Weiping Cai
Publikováno v:
Indian Journal of Medical Microbiology, Vol 36, Iss 4, Pp 513-516 (2018)
Backgrounds: This randomised controlled, open-label, non-inferiority trial was conducted in antiretroviral-naïve HIV-1-infected patients to assess the efficacy and safety of 48-week dual therapy of LPV/r plus 3TC (DT group) compared with Chinese fir